BioStem Technologies
(OTC) BSEM
BioStem Technologies Financials at a Glance
Market Cap
$63.96M
Revenue (TTM)
-$18.91M
Net Income (TTM)
-$19.88M
EPS (TTM)
-$1.19
P/E Ratio
-3.28
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$4.02
Volume
16,770
Open
$3.90
Price
$4.02
Volume
16,770
Open
$3.90
Previous Close
$3.92
Daily Range
$3.90 - $4.25
52-Week Range
$3.09 - $13.80
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$4.02
Volume
16,770
Open
$3.90
Previous Close
$3.92
Daily Range
$3.90 - $4.25
52-Week Range
$3.09 - $13.80
Estimated Earnings Date
Aug 13, 2026
BSEM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioStem Technologies
Industry
Pharmaceuticals
Sector
Health CareEmployees
24
CEO
Jason Matuszewski
Website
www.biostemtechnologies.comHeadquarters
Pompano Beach, FL 33064, US
BSEM Financials
Key Financial Metrics (TTM)
Gross Margin
1%
Operating Margin
78%
Net Income Margin
1%
Return on Equity
-50%
Return on Capital
-46%
Return on Assets
-36%
Earnings Yield
-30.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$63.96M
Shares Outstanding
16.34M
Volume
16.77K
Avg. Volume
63.87K
Financials (TTM)
Gross Profit
$44.22M
Operating Income
-$689.15K
EBITDA
-$469.73K
Operating Cash Flow
$9.94M
Capital Expenditure
-$3.35M
Free Cash Flow
$6.59M
Cash & ST Invst.
$29.55M
Total Debt
$3.33M
BioStem Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.14M
-91.5%
Gross Profit
$3.22M
-95.5%
Gross Margin
52.47%
N/A
Market Cap
$63.96M
N/A
Market Cap/Employee
$31.98M
N/A
Employees
2
N/A
Net Income
-$8.82M
-296.7%
EBITDA
-$8.34M
-257.3%
Quarterly Fundamentals
Total Cash
$13.70M
-48.6%
Total Debt
$3.28M
-23.8%
Accounts Receivable
$6.20M
-94.3%
Inventory
$4.50M
+128.2%
Long Term Debt
$44.64K
-85.2%
Short Term Debt
$3.24M
-19.2%
Return on Assets
-36.10%
N/A
Return on Invested Capital
-46.45%
N/A
Free Cash Flow
$2.39M
-70.2%
Operating Cash Flow
$2.83M
-65.3%